Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077)

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077)'. Together they form a unique fingerprint.

Medicine & Life Sciences